date:Jun 13, 2012
ficant reductions of about 30% in both fasting insulin levels and insulin resistance.
In addition, the chromium dinicocysteinate group also displayed significantly reduced levels of the inflammatory cytokine TNF-alpha (21%) and significantly reduced the oxidative stress marker protein carbonyl (10%).
On the other hand, the chromium picolinate group did not display significant changes in insulin levels, insulin resistance, TNF-alpha and protein carbonyl levels compared to baseline values, said